90 related articles for article (PubMed ID: 17121137)
41. Protein patterns and proteins that identify subtypes of glioblastoma multiforme.
Furuta M; Weil RJ; Vortmeyer AO; Huang S; Lei J; Huang TN; Lee YS; Bhowmick DA; Lubensky IA; Oldfield EH; Zhuang Z
Oncogene; 2004 Sep; 23(40):6806-14. PubMed ID: 15286718
[TBL] [Abstract][Full Text] [Related]
42. Multicentric glioblastoma multiforme occurring in the supra- and the infratentorial regions--case report.
Kudo H; Tanaka M; Urui S; Suzuki H; Tamaki N; Matsumoto S
Neurol Med Chir (Tokyo); 1990 May; 30(5):334-8. PubMed ID: 1699150
[TBL] [Abstract][Full Text] [Related]
43. Second primary glioblastoma.
Reis RM; Herva R; Brandner S; Koivukangas J; Mironov N; Bär W; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 2001 Feb; 60(2):208-15. PubMed ID: 11273008
[TBL] [Abstract][Full Text] [Related]
44. Tumor-free survival of 7 years after gene therapy for recurrent glioblastoma.
Floeth FW; Langen KJ; Reifenberger G; Weber F
Neurology; 2003 Jul; 61(2):270-1. PubMed ID: 12874421
[No Abstract] [Full Text] [Related]
45. Sarcoma with true epithelial differentiation secondary to irradiated glioblastoma.
Pimentel J; Marques J; Pereira P; Roque L; Martins C; Campos A
Clin Neuropathol; 2011; 30(6):307-12. PubMed ID: 22011736
[TBL] [Abstract][Full Text] [Related]
46. Clinical characteristics and prognosis of Glioblastoma patients with infratentorial recurrence.
Kawauchi D; Ohno M; Honda-Kitahara M; Miyakita Y; Takahashi M; Yanagisawa S; Tamura Y; Kikuchi M; Ichimura K; Narita Y
BMC Neurol; 2023 Jan; 23(1):9. PubMed ID: 36609238
[TBL] [Abstract][Full Text] [Related]
47. Infratentorial congenital glioblastoma multiforme. A rare tumour with a still unknown biology.
Salas S; Agut T; Rovira C; Canizo D; Lavarino C; Garcia-Alix A
Rev Neurol; 2016 Nov; 63(9):411-414. PubMed ID: 27779301
[TBL] [Abstract][Full Text] [Related]
48. EGFR Amplification in a Patient with Glioblastoma: A Case Report and Review of the Literature.
Hurtado R; Peng E; Yee J; Tran C; Glaser J; Tirado CA
J Assoc Genet Technol; 2022; 48(1):24-31. PubMed ID: 35247256
[TBL] [Abstract][Full Text] [Related]
49. Long-term survival in patients with supratentorial glioblastoma.
Salvati M; Cervoni L; Artico M; Caruso R; Gagliardi FM
J Neurooncol; 1998 Jan; 36(1):61-4. PubMed ID: 9525826
[TBL] [Abstract][Full Text] [Related]
50. Prognostic stratification of adult primary glioblastoma multiforme patients based on their tumor gene amplification profiles.
González-Tablas M; Crespo I; Vital AL; Otero Á; Nieto AB; Sousa P; Patino-Alonso MC; Corchete LA; Tão H; Rebelo O; Barbosa M; Almeida MR; Guedes AF; Lopes MC; French PJ; Orfao A; Tabernero MD
Oncotarget; 2018 Jun; 9(46):28083-28102. PubMed ID: 29963263
[TBL] [Abstract][Full Text] [Related]
51. [Bone metastasis from a glioblastoma: An unusual course!].
Chelly I; Mekni A; Ferchichi L; Houissa S; Kchir N; Haouet S; Khaldi M; Zitouna M
Neurochirurgie; 2006 Sep; 52(4):367-70. PubMed ID: 17088717
[TBL] [Abstract][Full Text] [Related]
52. Glioblastoma Multiforme With CDKN2A, Loss of PTEN and EGFR Amplification, and Diffuse Distant Organ Metastasis Treated With Six Lines of Therapy: A Case Report and Literature Review.
Aslan F; Günaydın E; Yukruk F; Güvenç İ; Gençler OS
Cureus; 2022 Apr; 14(4):e23796. PubMed ID: 35518520
[TBL] [Abstract][Full Text] [Related]
53. The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy.
Zhou YH; Chen Y; Hu Y; Yu L; Tran K; Giedzinski E; Ru N; Gau A; Pan F; Qiao J; Atkin N; Ly KC; Lee N; Siegel ER; Linskey ME; Wang P; Limoli C
Oncotarget; 2017 Oct; 8(46):80853-80868. PubMed ID: 29113349
[No Abstract] [Full Text] [Related]
54. [Glioblastom nach Leukotomie].
HEYCK H
Monatsschr Psychiatr Neurol; 1954 Sep; 128(3):180-8. PubMed ID: 13213972
[No Abstract] [Full Text] [Related]
55. Relationship of cranial to subjacent cerebral tumors; report of case of fibrosarcoma eroding frontal bone associated with an underlying gliobiastoma multiforme.
COURVILLE CB; EDMONDSON HA
Bull Los Angel Neuro Soc; 1953 Jun; 18(2):103-9. PubMed ID: 13059572
[No Abstract] [Full Text] [Related]
56. Case presentation - A five-year survival of the patient with glioblastoma brain tumor.
Urbańczyk H; Strączyńska-Niemiec A; Głowacki G; Lange D; Miszczyk L
Rep Pract Oncol Radiother; 2014 Sep; 19(5):347-51. PubMed ID: 25184061
[TBL] [Abstract][Full Text] [Related]
57. Plasma nanoDSF Denaturation Profile at Baseline Is Predictive of Glioblastoma EGFR Status.
Eyraud R; Ayache S; Tsvetkov PO; Kalidindi SS; Baksheeva VE; Boissonneau S; Jiguet-Jiglaire C; Appay R; Nanni-Metellus I; Chinot O; Devred F; Tabouret E
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765718
[TBL] [Abstract][Full Text] [Related]
58. [Pre- and postoperative evaluation of a frontal lobe tumor of 8 years duration].
SCHACHTER M
Praxis; 1952 Aug; 41(32):697-700. PubMed ID: 13003880
[No Abstract] [Full Text] [Related]
59. [Some considerations on a case of prefrontal tumor].
LUQUE O; JUNCOS RA
Rev Fac Cienc Med Univ Nac Cordoba; 1953; 11(1-2):5-10. PubMed ID: 13100992
[No Abstract] [Full Text] [Related]
60. Erratum to: Primary glioblastoma multiforme tumors and recurrence: comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.
Muth C; Rubner Y; Semrau S; Rühle PF; Frey B; Strnad A; Buslei R; Fietkau R; Gaipl US
Strahlenther Onkol; 2016 Mar; 192(3):156. PubMed ID: 26809739
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
